207 related articles for article (PubMed ID: 11327101)
1. The pleiotropic functions of peroxisome proliferator-activated receptor gamma.
Debril MB; Renaud JP; Fajas L; Auwerx J
J Mol Med (Berl); 2001; 79(1):30-47. PubMed ID: 11327101
[TBL] [Abstract][Full Text] [Related]
2. PPAR gamma: an essential role in metabolic control.
Fajas L; Debril MB; Auwerx J
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):64-9. PubMed ID: 11383325
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Yamauchi T; Waki H; Kamon J; Murakami K; Motojima K; Komeda K; Miki H; Kubota N; Terauchi Y; Tsuchida A; Tsuboyama-Kasaoka N; Yamauchi N; Ide T; Hori W; Kato S; Fukayama M; Akanuma Y; Ezaki O; Itai A; Nagai R; Kimura S; Tobe K; Kagechika H; Shudo K; Kadowaki T
J Clin Invest; 2001 Oct; 108(7):1001-13. PubMed ID: 11581301
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
5. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
Desreumaux P; Dubuquoy L; Nutten S; Peuchmaur M; Englaro W; Schoonjans K; Derijard B; Desvergne B; Wahli W; Chambon P; Leibowitz MD; Colombel JF; Auwerx J
J Exp Med; 2001 Apr; 193(7):827-38. PubMed ID: 11283155
[TBL] [Abstract][Full Text] [Related]
7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
8. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
[TBL] [Abstract][Full Text] [Related]
9. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases.
Dubuquoy L; Dharancy S; Nutten S; Pettersson S; Auwerx J; Desreumaux P
Lancet; 2002 Nov; 360(9343):1410-8. PubMed ID: 12424006
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
Fajas L; Debril MB; Auwerx J
J Mol Endocrinol; 2001 Aug; 27(1):1-9. PubMed ID: 11463572
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma, the ultimate liaison between fat and transcription.
Rocchi S; Auwerx J
Br J Nutr; 2000 Dec; 84 Suppl 2():S223-7. PubMed ID: 11242474
[TBL] [Abstract][Full Text] [Related]
12. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Wang M; Tafuri S
J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
[TBL] [Abstract][Full Text] [Related]
13. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK
J Clin Invest; 2000 Aug; 106(4):523-31. PubMed ID: 10953027
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.
Rocchi S; Auwerx J
Ann Med; 1999 Oct; 31(5):342-51. PubMed ID: 10574507
[TBL] [Abstract][Full Text] [Related]
16. p120 acts as a specific coactivator for 9-cis-retinoic acid receptor (RXR) on peroxisome proliferator-activated receptor-gamma/RXR heterodimers.
Monden T; Kishi M; Hosoya T; Satoh T; Wondisford FE; Hollenberg AN; Yamada M; Mori M
Mol Endocrinol; 1999 Oct; 13(10):1695-703. PubMed ID: 10517671
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
Argmann CA; Sawyez CG; McNeil CJ; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):475-82. PubMed ID: 12615696
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic significance of peroxisome proliferator-activated receptor modulators in diabetes.
Ram VJ
Drugs Today (Barc); 2003 Aug; 39(8):609-32. PubMed ID: 14566384
[TBL] [Abstract][Full Text] [Related]
20. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling.
Adamson DJ; Frew D; Tatoud R; Wolf CR; Palmer CN
Mol Pharmacol; 2002 Jan; 61(1):7-12. PubMed ID: 11752200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
